Clinical trial
Neurocognitive Effects of Ziprasidone: Relationship to Working Memory and…
NCT00225498 · Northwell Health, Other · Completed
Key facts
| NCT number | NCT00225498 |
|---|---|
| Title | Neurocognitive Effects of Ziprasidone: Relationship to Working Memory and Dopamine Blockade |
| Official title | Neurocognitive Effects of Ziprasidone: Relationship to Working Memory and Dopamine Blockade |
| Lead sponsor | Northwell Health, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | ziprasidone vs risperidone or olanzapine |
| Enrollment | 35 |
| Start date | Jun 1, 2002 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Sep 23, 2005 |
| Last update posted | Sep 10, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: